IsraelLawWhen a foreign national invests in an Israeli startup or acquires a minority stake in an Israeli private company, they often find themselves holding economic exposure but little actual control. The majority shareholder runs the board, approves management decisions, and determines dividend policy. In theory, this creates room for abuse: dilution through below-price share issuances, self-dealing transactions with related parties, exclusion from financial information, or simply running the company in a way that serves the majority at the minority's expense.
Israeli law addresses some of these risks automatically through the Companies Law 5759-1999. Others require deliberate negotiation before you invest. This guide walks through both, with examples from Israeli court practice.
1. Overview of Israeli Corporate Law
The governing statute for all Israeli companies is the Companies Law 5759-1999 (*Hok HaHavarot*), which replaced the earlier Companies Ordinance (New Version) 5743-1983. It applies to all Israeli limited liability companies (*hevrot be'eravon mugbal*) — both private and public — and sits alongside sector-specific legislation such as the Securities Law 5728-1968, which applies to public companies listed on the Tel Aviv Stock Exchange (TASE).
For minority shareholder purposes, three layers of law interact:
- Mandatory statutory rights built into the Companies Law — these apply automatically to all shareholders and cannot be removed by the company's articles or by private agreement
- Default rights in the Articles of Association (*takanon*) — these apply unless the articles modify them, and the articles of many Israeli private companies do so extensively
- Contractual rights in a shareholders' agreement (*heskem baalei mehamot*) — negotiated privately and binding only on the parties who sign
Foreign nationals face no ownership restrictions in Israeli private companies. Unlike some countries, Israel does not impose foreign investment approval requirements for private company shareholdings below specific thresholds in regulated sectors (defence, telecommunications, and certain infrastructure assets are exceptions). For the typical startup investment or family business stake, no government approval is required solely on account of the investor being a foreigner.
2. Statutory Rights Under the Companies Law 5759-1999
The Companies Law grants minority shareholders a set of baseline rights that no provision in the articles or any private agreement can take away. These rights apply to every Israeli private company automatically.
Right to Call a General Meeting (Section 63)
Shareholders holding at least 5% of the issued share capital can require the board to convene an extraordinary general meeting. The board must give notice within 21 days of the demand, and the meeting itself must be held within 35 days of that notice. If the board ignores the demand, the requesting shareholders may convene the meeting themselves. This is the minority's most direct tool for forcing a vote — whether on a contested transaction, a proposed dividend, or the removal of a director.
Right to Financial Information (Sections 172–175)
Every shareholder, regardless of stake size, has the right to receive the company's annual financial statements. For private companies, this means audited accounts must be provided to shareholders on request. A shareholder holding at least 1% of issued capital can also request to inspect the company's register of shareholders, the register of directors, and the register of charges — all of which are also available through the Companies Registrar (*Rasham HaHavarot*) at the Ministry of Justice.
Voting Rights and Special Majority Requirements
Each ordinary share normally carries one vote at general meetings, unless the articles specify otherwise. Ordinary resolutions require a simple majority. Extraordinary resolutions — such as amending the articles, authorizing a share buyback, or approving certain fundamental transactions — require a special majority of 75% of the votes cast. This means minority shareholders collectively holding more than 25% of voting rights can block extraordinary resolutions, even without a contractual veto right.
Protection Against Related-Party Transactions (Sections 255–277)
Transactions between the company and a controlling shareholder — defined as someone holding 50% or more of voting rights, or who has the practical ability to appoint a majority of directors — require a three-stage approval process under Sections 270–275 of the Companies Law. The transaction must be approved by the audit committee (for public companies) or a disinterested director majority (for private companies), by the full board, and then by a general meeting in which a majority of the minority votes are cast in favor. This "disinterested majority" requirement is the principal statutory weapon against self-dealing by majority shareholders.
A US-based angel investor held 9% of an Israeli med-tech company. The controlling shareholder (holding 61%) proposed selling the company's flagship patent to a holding company he personally owned, at a valuation that independent experts later assessed as 40% below market. Under Section 275 of the Companies Law, the transaction required approval by a majority of the minority shareholders at a general meeting. The angel investor coordinated with two other minority holders. Together they held 23% of the minority vote — enough to defeat the resolution when combined with the requirement that a majority of minority votes approve the deal. The transaction was blocked, and the company eventually sold the patent to a third party at a much higher price eight months later.
3. Shareholder Agreement Protections
The statutory floor is meaningful, but it leaves many risks unaddressed. Before closing, negotiate a shareholders' agreement that covers the gaps. The following protections are standard in Israeli venture capital and private equity transactions.
Anti-Dilution Rights
If the company later issues shares at a price lower than what you paid — a "down round" — anti-dilution provisions adjust your conversion ratio or entitle you to additional shares to compensate for the economic dilution. Israeli practice typically uses broad-based weighted average anti-dilution rather than full ratchet, which is more investor-friendly but less punitive to founders. Without an anti-dilution clause, a minority shareholder has no statutory right to protection against a down-round dilution.
Pre-emption Rights (Right of First Refusal)
Before any shareholder can sell their shares to a third party, pre-emption rights require them to first offer those shares to existing shareholders on the same price and terms. Israeli shareholders' agreements typically give a 30-day exercise window. This protects existing minority holders from finding themselves alongside an unwanted new entrant who acquires a large block from a departing founder.
Tag-Along Rights
If the majority shareholder sells their stake to a buyer, tag-along rights give minority shareholders the right to join the sale on the same price and terms. Without tag-along rights, a buyer can acquire majority control and the minority is left holding shares in a company under new management they had no say in selecting, usually at a lower effective value than the majority received per share.
Drag-Along Rights
The mirror provision: if a buyer wants to acquire 100% of the company, drag-along rights allow the majority to compel minority shareholders to sell their shares on the same terms. While this limits minority exit flexibility, it also means the minority shares in whatever control premium the buyer is willing to pay. Most sophisticated minority investors accept drag-along provisions provided the agreed trigger price is at least equal to their cost basis plus a specified minimum return.
Board Representation Rights
The Companies Law does not automatically give a minority shareholder board representation. A director can only be appointed at a general meeting by shareholders holding a majority of voting rights, unless the articles contain specific board appointment rights. Investors holding 10%–20% of a company routinely negotiate a contractual right to appoint one director. This is negotiated in the shareholders' agreement, not through the articles, and binds only the signatories.
Information Rights
Beyond the statutory minimum, investors with board seats routinely negotiate quarterly financial statements, board minutes within 14 days of each meeting, immediate notice of material events (a new funding round, any dispute above a defined threshold, senior management departures), and the right to appoint a non-voting observer to board meetings.
A German family office invested NIS 3.5 million in an Israeli food-tech company in 2023, acquiring an 18% stake at a per-share price of NIS 14. Two years later, the founders proposed raising a bridge round at NIS 6 per share — a significant down round driven by a delay in their product launch. Without intervention, the family office's stake would have fallen from 18% to below 9%. Their shareholders' agreement contained a broad-based weighted average anti-dilution clause. Under the formula, their existing shares were adjusted to give them additional ordinary shares equivalent to the economic dilution suffered. They also exercised their pre-emption right to participate in the new round, maintaining their 18% position at a blended cost basis. The contractual rights saved what would otherwise have been a substantial loss of both economic position and board influence.
4. Derivative Actions and Oppression Remedies
When statutory or contractual rights are actually violated, not just threatened, the Companies Law provides two primary judicial remedies for minority shareholders.
The Derivative Action (Section 194)
A derivative action is a claim brought by a shareholder on the company's behalf, typically against a director or officer who wronged the company by breaching their fiduciary duty or duty of care under Sections 252–260 of the Companies Law. The action is derivative because the cause of action belongs to the company, but the shareholder initiates it when the company itself (under the control of the wrongdoer's allies) refuses to act.
Before filing, the shareholder must give the company written notice and a reasonable opportunity to take action itself. If the company does not act within a reasonable period — courts have treated 30 to 60 days as reasonable depending on circumstances — the shareholder may apply to the court for leave to file the derivative claim. The court grants leave if satisfied that: (a) the claim is prima facie arguable; (b) the applicant is acting in good faith and in the company's interest; and (c) there is reason to believe the action is not detrimental to the company.
The Oppression Remedy (Section 191)
This is the most powerful and frequently used remedy for Israeli minority shareholders. Under Section 191, any shareholder may petition the court if the company's affairs are being conducted in a manner that is "oppressive" (*meitza*) to a minority shareholder, or if a decision has been made that "unfairly disregards" the minority's interests. The threshold covers both legal wrongs and broader conduct that breaches the reasonable expectations of the parties when they invested.
Israeli courts have held that oppression extends to situations such as:
- Excluding a shareholder from management when they invested with the expectation of participation
- Issuing new shares to dilute a specific shareholder rather than for genuine commercial reasons
- Paying excessive management fees or salaries to related parties at the company's expense
- Withholding dividends from a profitable company to squeeze out a minority
- Removing a minority shareholder from a board seat they had a reasonable expectation of holding
The remedies available under Section 191 are wide and court-calibrated to the circumstances. The court may order:
- The majority to buy out the minority's shares at a court-determined fair value
- The minority to buy out the majority's shares (rare, but used where the majority wish to exit)
- The oppressive act or resolution to be set aside
- A specific act to be performed (such as calling a general meeting or making a distribution)
- The appointment of an independent director to the board
- Winding up of the company in extreme cases
A US investor held a 12% stake in an Israeli SaaS company. The controlling shareholder, who also served as CEO, stopped paying dividends for four consecutive profitable years, awarded himself a salary of NIS 720,000 per year (more than three times the market rate for a company of that size), and stopped providing the investor with board minutes or management accounts. The investor filed a Section 191 petition in the Tel Aviv Economic Court. The court found that the pattern of conduct — excessive compensation combined with information exclusion and dividend withholding — constituted oppression. It ordered the controlling shareholder to buy out the minority at a fair market value determined by an independent valuator appointed by the court. The buyout was completed approximately eight months after the petition was filed, at a price 22% higher than the controlling shareholder had offered privately before proceedings began.
5. Enforcing Minority Shareholder Rights in Israeli Courts
The Tel Aviv Economic Court
The Tel Aviv Economic Court (*Beit Mishpat Kalkali*, established in 2010) is a specialist division of the Tel Aviv District Court with dedicated judges for corporate, securities, insolvency, and complex commercial disputes. Nearly all significant minority shareholder claims in Israel — derivative actions, Section 191 oppression petitions, disputes over related-party transactions — are filed here. Initial hearings are typically scheduled within 6–10 weeks of filing. For companies registered in other districts, the relevant District Court handles corporate matters.
Filing Fees
Court filing fees in Israel are calculated as a percentage of the amount in dispute under the Court Fees Regulations 5767-2007. For a monetary claim of NIS 1 million, the fee is approximately NIS 8,000. For NIS 5 million, approximately NIS 25,000. Oppression petitions seeking non-monetary relief (such as a share buyout at a price to be determined) attract a fixed fee of approximately NIS 4,000 at filing, with a supplementary fee payable once the value is quantified.
Interim Injunctions
Israeli courts can grant interim injunctions (*tzav airzur* or *tzav ezem*) to freeze a transaction or preserve the status quo while full proceedings are pending. Applications for interim relief are heard on short notice — sometimes within 48 hours in genuinely urgent cases — but the applicant must satisfy the court on three points: that there is an arguable prima facie case; that the balance of convenience favors the injunction; and that the harm from refusing the injunction outweighs the harm from granting it.
Arbitration
Many Israeli shareholders' agreements include mandatory arbitration clauses, often designating the Israel Center for Commercial Arbitration (ICCA) as the administering institution. ICCA arbitration is governed by the Israeli Arbitration Law 5728-1968. For corporate disputes under NIS 2 million, proceedings typically conclude within 12 months. For larger or more complex matters, 18–24 months is more realistic. ICCA arbitration offers privacy (proceedings are confidential) and faster scheduling than the Economic Court for mid-sized disputes. However, interim relief still requires a court application, as the arbitral tribunal has limited coercive powers under Israeli law without court confirmation.
A Canadian investor holding 14% of a Tel Aviv-based proptech company learned on a Thursday evening that the controlling shareholder had signed a letter of intent to sell the company's core software platform to a company he personally controlled, at a price that represented less than 30% of the most recent independent valuation. The investor's Israeli attorney filed an emergency application for an interim injunction the same evening. An Economic Court judge heard the application the following Sunday morning (Israeli courts sit Sunday through Thursday). The injunction was granted by Sunday afternoon — within 72 hours of filing — freezing the proposed transaction pending a full hearing. The controlling shareholder ultimately withdrew the related-party transaction and engaged an independent financial adviser to run a competitive sale process in which the investor's tag-along rights were exercised.
6. What Foreign Investors Should Do Before Investing
Protecting minority shareholder rights starts before you transfer the funds. Here is what that due diligence process looks like in practice.
Review the Articles of Association in Detail
The company's registered articles (*takanon*) are a public document, available through the Companies Registrar online portal at the Ministry of Justice website. Read them carefully with a qualified Israeli attorney before signing anything. Check whether the articles include pre-emption rights on share transfers, whether they can be amended by simple majority (which would allow the majority to remove your protections unilaterally), and whether existing articles give the board discretion to issue shares without shareholder approval. Many standard-form Israeli articles give the board very broad powers to issue shares, which can be used to dilute minority positions without a shareholder vote.
Negotiate a Shareholders' Agreement
Do not rely on the articles alone. A shareholders' agreement binds all signatories with more detailed investor protections than articles typically contain. At minimum, it should address: anti-dilution provisions (specifying the formula), pre-emption rights (with a clearly defined exercise window and mechanism), tag-along rights (covering all share transfers above a specified threshold), drag-along provisions (with a minimum exit price floor), board appointment rights, information rights (quarterly statements, board minutes, material event notices), a defined dispute resolution mechanism, and a governing law clause specifying Israeli law or a chosen foreign law.
Check the Register of Charges
Before closing, conduct a search of the Companies Registrar's register of charges (*pnkas hashiabud*) for the company. The Registrar records all charges (*shiabud*) and floating charges (*mishkanta tsafah*) over company assets, including charges over shares. A search costs approximately NIS 50 and takes minutes online. Do not acquire shares in a company that has pledged its assets as security without understanding what the charge covers and whether it has priority over your future claims as a shareholder.
Verify Corporate Good Standing
Request a certificate of good standing (*teudat metsav*) from the Companies Registrar confirming the company is properly registered, current on its annual filing obligations, and not in dissolution or winding-up proceedings. The Registrar issues this document within 3–5 business days. A company that has fallen behind on annual reports to the Registrar may be struck off the register, which can complicate enforcement of your shareholder rights.
Register the Share Transfer
Once you acquire shares, the transfer must be registered with the Companies Registrar within 3 business days of the share transfer date, and with the company's internal shareholder register. Failure to register does not invalidate the transfer between the parties, but it can affect your rights vis-a-vis third parties, including creditors of the company who may later claim priority over unregistered equity interests.
Specify a Valuation Mechanism for Dispute Scenarios
Many minority shareholder disputes in Israel arise not from the parties' disagreement about rights, but from their inability to agree on what the shares are worth when a buyout mechanism is triggered. Agree in the shareholders' agreement on a specific valuation methodology — whether that is an independent auditor's determination, a discounted cash flow model with defined parameters, or a multiple of trailing EBITDA. This one clause prevents months of costly litigation over valuation alone.
A UK-based diaspora investor acquired 15% of an Israeli real estate holding company for NIS 1.2 million without conducting a full review of the articles or searching the register of charges. He later discovered that the majority shareholder had previously granted a floating charge over all company assets — including the shares — to a commercial bank. He also discovered the articles permitted the board (controlled by the majority) to issue new shares to existing shareholders at a price set by the board, with no pre-emption right for non-participating shareholders. Within 18 months, his 15% stake was diluted to under 3% through two successive share issuances at NIS 0.10 per share — while he had paid NIS 5.00 per share. Neither the floating charge nor the articles issue would have been missed by an attorney conducting even a basic Companies Registrar search. His legal options were severely limited because no contractual protections were in place and no statutory protection applied to the dilutive issuances under those circumstances.